M.D. Anderson Cancer Center: Nausea trials

The registry lists 12 Nausea studies with M.D. Anderson Cancer Center as lead sponsor. 0 are open to participants now and 7 have results posted.

Phase 1 1Phase 2 4Phase 3 4No phase 5(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Netupitant and Palonosetron Hydrochloride in Preventing Chronic Nausea and Vomiting in Patients With CancerCompletedNCT03040726Phase 2/3Results posted
• Fosaprepitant in Patients Receiving Ifosfamide-based RegimenCompletedNCT01490060Not applicableResults posted
• Palonosetron Versus Ondansetron for the Prevention of Nausea and VomitingCompletedNCT01031498Phase 2Results posted
• Palonosetron and Dexamethasone With or Without Dronabinol in Preventing Nausea and Vomiting in Patients Receiving Chemotherapy For CancerCompletedNCT00553059Phase 3Results posted
• Dexamethasone for Symptom Burden in Advanced Cancer PatientsActive, not recruitingNCT00489307Phase 2Results posted
• Palonosetron for Prevention of Biochemotherapy Induced Nausea and VomitingCompletedNCT00412425Phase 1/2Results posted
• Palonosetron in Sarcoma Patients Receiving Chemotherapy With Adriamycin and Ifosfamide (AI)CompletedNCT00410488Not applicableResults posted
• Domperidone in Treating Patients With Gastrointestinal DisordersActive, not recruitingNCT01696734Phase 3
• Effects of Acupoint Electro-stimulation on Preventing Nausea and Vomiting Induced by Cisplatin or OxaliplatinWithdrawnNCT00430313Not applicable
• Chemoradiation-Induced Nausea and Emesis: Quality of LifeTerminatedNCT00394602
• Mindfulness Relaxation Compared With Relaxing Music and Standard Symptom Management Education in Treating Patients Who Are Undergoing Chemotherapy For Newly Diagnosed Solid TumorsCompletedNCT00086762Not applicable
• Acupressure in Treating Nausea in Women Receiving Combination Chemotherapy for Breast CancerCompletedNCT00046865Phase 3